Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Total 13F shares
-
1,116,093
-
Share change
-
+246,976
-
Total reported value
-
$2,823,000
-
Put/Call ratio
-
66%
-
Price per share
-
$2.53
-
Number of holders
-
17
-
Value change
-
+$624,930
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q4 2020
As of 31 Dec 2020 Arcadia Biosciences, Inc. - Common Stock (RKDA) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,116,093 shares of stock of the company.
Largest 10 holders included ARDSLEY ADVISORY PARTNERS LP, VANGUARD GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, WELLS FARGO & COMPANY/MN, LPL Financial LLC, BlackRock Inc., and HighTower Advisors, LLC.
This table shows 17 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.